Help with healthcare costs for ovarian cancer (health equity fund)
This TotalAssist fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses. Check your eligibility with our quick and easy tools below. If this fund is open, apply today for an instant approval decision and use your grant funding right away. Learn how TotalAssist helps you.
Health Equity Funds offer help to eligible patients living in areas identified as having increased social and financial needs, as well as higher rates of chronic conditions. Eligibility is determined in part by home address zip code.
TotalAssist also offers an ovarian cancer fund. Please note that you cannot receive more than one grant for the same condition.
Eligibility criteria
To be eligible for this fund, you must:
- Have a confirmed diagnosis and are in treatment for ovarian cancer, or planning to begin treatment in the next 60 days, or have been in treatment in the past 6 months. This includes active surveillance of a condition
- Have government-insured coverage that covers your qualifying expenses
- Have an income at or less than 500% of the Federal Poverty Level, adjusted for your regional Cost of Living Index (COLI). What is this?
- Be a legal resident and receive treatment in the U.S. or a U.S. territory
- Be prescribed a medication or product listed in the approved medications, listed below
- Have a home address in a zip code served by a Health Equity Fund, which supports eligible patients living in designated social vulnerability counties
Quick eligibility checker
- Treatment
- Insurance
- Income
Approved medications
Patient Advocate Foundation covers all the prescription medications for each diagnosis, including generic or bioequivalent drugs, that meet any of the following criteria: FDA-approved, listed in official compendia, and/or listed in published evidence-based or clinical guidelines.
- Abraxane (Paclitaxel Protein-Bound)
- Adriamycin (Doxorubicin Hydrochloride)
- Alimta (Pemetrexed Disodium)
- Alkeran (Melphalan)
- Alymsys (Bevacizumab-Maly)
- Anastrozole (Anastrozole)
- Arimidex (Anastrozole)
- Aromasin (Exemestane)
- Augtyro (Repotrectinib)
- Avastin (Bevacizumab)
- Axtle (Pemetrexed)
- Beizray (Docetaxel)
- Blenoxane (Bleomycin Sulfate)
- Cisplatin (Cisplatin)
- Cyclophosphamide (Cyclophosphamide)
- Dactinomycin (Dactinomycin)
- Docetaxel (Docetaxel)
- Docivyx (Docetaxel)
- DOXIL (Doxorubicin Hcl Liposomal)
- Elahere (Mirvetuximab Soravtansine-Gynx)
- Enhertu (Trastuzumab Deruxtecan-Nxki)
- Etopophos (Etoposide Phosphate)
- Etoposide (Etoposide)
- Exemestane (Exemestane)
- Faslodex (Fulvestrant)
- Femara (Letrozole)
- Fluorouracil (Fluorouracil)
- Frindovyx (Cyclophosphamide)
- Fulvestrant (Fulvestrant)
- Gemcitabine Hcl (Gemcitabine)
- Ifex (Ifosfamide)
- Ifosfamide (Ifosfamide)
- Irinotecan Hcl (Irinotecan)
- Ivra (Melphalan)
- Jemperli (Dostarlimab-Gxly)
- Jobevne (Bevacizumab-Nwgd)
- Keytruda (Pembrolizumab)
- Letrozole (Letrozole)
- Leuprolide Acetate (Leuprolide Acetate)
- Leuprolide Depot (Leuprolide Acetate)
- Lifyorli (Relacorilant)
- Lupron Depot (Leuprolide Acetate)
- Lupron Depot-Ped (Leuprolide Acetate)
- Lutrate Depot (Leuprolide Acetate)
- Lynparza (Olaparib)
- Megestrol Acetate (Megestrol Acetate)
- Mekinist (Trametinib)
- Mektovi (Binimetinib)
- Melphalan (Melphalan)
- Mvasi (Bevacizumab-Awwb)
- Nexavar (Sorafenib)
- Oxaliplatin (Oxaliplatin)
- Paclitaxel (Paclitaxel)
- Paclitaxel Protein-Bound (Paclitaxel Protein-Bound)
- Paraplatin (Carboplatin)
- Pemetrexed (Pemetrexed)
- Pemetrexed Disodium (Pemetrexed Disodium)
- Retevmo (Selpercatinib)
- Rozlytrek (Entrectinib)
- Rubraca (Rucaparib)
- Soltamox (Tamoxifen Citrate)
- Sorafenib (Sorafenib Tosylate)
- Tamoxifen Citrate (Tamoxifen Citrate)
- Tepadina (Thiotepa)
- Tepylute (Thiotepa)
- Thiotepa (Thiotepa)
- Topotecan Hcl (Topotecan Hydrochloride)
- Vegzelma (Bevacizumab-Adcd)
- Vinblastine Sulfate (Vinblastine Sulfate)
- Vincristine Sulfate (Vincristine Sulfate)
- Vitrakvi (Larotrectinib Sulfate)
- Votrient (Pazopanib)
- Xeloda (Capecitabine)
- Zejula (Niraparib)
- Zirabev (Bevacizumab-Bvzr)
About the disease
Ovarian cancer is a type of cancer that begins in the ovaries. This condition affects biological females. It affects the female reproductive system.
Diagnosis codes
C56.1, C56.2, C56.3, C56.9
How to apply
-
If your fund is open, apply online 24/7, or call 866-512-3861, Monday – Friday, 8:30am – 5:30pm ET.
-
Answer pre-screening questions to confirm eligibility. Have your income, medication, diagnosis, and insurance information ready.
-
Complete the application and get an instant approval decision. You can begin using your grant right away.
Application guides
Questions?
Search help articles
Find answers to your questions about applying, claims, grant use, and your portal account.
Search help
How does it work?
You can use your TotalAssist grant award to help pay for out-of-pocket healthcare expenses.
Learn more
Need help applying?
Call us at 866-512-3861 to apply by phone, Monday through Friday, 8:30am - 5:30pm ET.
Contact usRelated organizations
Connect with other organizations and resources for support.
Featured partner:
SHARE Cancer Support provides support and education for all individuals diagnosed with breast or gynecologic cancers. They offer online support groups, helplines, and educational webinars, connecting patients with trained peers and trusted resources. SHARE also provides information on signs and symptoms through public outreach.
Get support
Explore resources beyond TotalAssist
Patient Advocate Foundation knows that patients may need support, information, and resources beyond TotalAssist. This can include services like case management, help with living expenses, and much more. Search our National Financial Resources Directory, find community specific resources, and explore our patient education library.
Find resources